From: Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
 | Non-NASH patients | NASH patients | P value |
---|---|---|---|
Age (years) | 49.0 ± 15.3 | 52.8 ± 13.5 | 0.2995 |
BMI (m/kg2) | 27.6 ± 5.1 | 28.9 ± 6.0 | 0.3989 |
VFA (cm2) | 128.6 ± 55.7 | 133.3 ± 58.8 | 0.8031 |
SFA (cm2) | 196.9 ± 61.4 | 232.5 ± 120.9 | 0.3765 |
AST (U/ml) | 35.7 ± 17.5 | 63.4 ± 40.7 | 0.0031 |
ALT (U/ml) | 56.8 ± 31.5 | 89.9 ± 55.7 | 0.0115 |
FBS (mg/dl) | 118.7 ± 39.9 | 118.2 ± 30.8 | 0.9586 |
IRI (ul/ml) | 13.6 ± 10.8 | 14.3 ± 8.2 | 0.7999 |
HOMA-IR | 3.47 ± 2.64 | 4.05 ± 2.54 | 0.4725 |
HDL cholesterol (mg/l) | 50.3 ± 12.6 | 49.3 ± 11.4 | 0.7463 |
LDL cholesterol (mg/l) | 133.7 ± 27.0 | 128.6 ± 39.3 | 0.5928 |
Triglyceride (mg/l) | 159.0 ± 48.9 | 162.8 ± 81.9 | 0.8502 |
Albumin | 4.51 ± 0.28 | 4.45 ± 0.51 | 0.6175 |
Platelet count | 25.8 ± 5.7 | 23.2 ± 8.0 | 0.1816 |
Hyaluronic acid (ng/dl) | 21.6 ± 15.1 | 50.1 ± 50.2 | 0.0373 |
Type IV collagen 7s (ng/dl) | 4.41 ± 0.98 | 5.14 ± 1.31 | 0.0611 |